Interim Management Statement for the quarter en...

For Immediate Release
                                                      6 November 2009
                            HYGEA VCT PLC

   INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED           30
                           SEPTEMBER 2009


Hygea  vct  plc  ('the  Company')  presents  its  interim  management
statement for the quarter ended  30 September 2009. This  constitutes
the Company's second interim  management statement for the  financial
year  ending  31  December  2009,  as  required  by  the  UK  Listing
Authority's Disclosure and Transparency Rule 4.3. This statement  has
been prepared solely  to provide additional  information in order  to
meet the requirements  of the Disclosure  and Transparency Rules  and
should not be relied on by shareholders, or any other party, for  any
other purpose.

The unaudited net asset  value per ordinary share  and the number  of
shares in  issue  at  30  September 2009  were  91.7p  and  8,115,376
respectively (30 June  2009: 75.3p and  8,115,376 respectively).  The
company presently holds in excess of £4.3 million in cash. There were
no shares held in Treasury at either date.

No shares have been issued or repurchased during the period.

During the  three months  ended 30  September 2009  the Company  made
further investments  in  Glide  Pharmaceutical  Technologies  Limited
(£100,400), Prosurgics  Limited  (£100,000),  Omega  Diagnostics  plc
(£50,270),  Arecor  Limited  (£362).   As  previously  reported,  the
Company disposed of its holdings in BioAnaLab Limited and DxS Limited
for cash considerations  of £822,678 and  £3,590,631 respectively.  A
further payment of £121,693 has been received since the period end in
respect of the sale of BioAnaLab Limited which sum is included in the
reported  net  asset  value.  The  Company  may  become  entitled  to
additional proceeds in respect  of the sale of  DxS Limited of up  to
£2.5 million over the next three years, none of which has been  taken
into account in the net asset value reported above.

The Directors are very  pleased to report  a significant increase  in
net asset value per share following the sale of two unquoted holdings
in  investee  companies,  following  which  they  have  reviewed  the
Company's strategy.  It  is  their intention  to  propose  an  annual
dividend of 5p per share at  the 2010 Annual General Meeting. In  the
meantime  the  Directors  are   reviewing  the  maintenance  of   VCT
qualifying status in  conjunction with their  advisers and expect  to
declare an interim dividend in early 2010.

 Your Directors will utilise part  of the current cash resources  for
follow-on  investments  in  existing   investee  companies  and   are
reviewing a number of new  investment opportunities which conform  to
its investment template.

In order to improve liquidity, the Company's shares will be traded on
Sharemark with effect from 9 November 2009 in addition to the  London
Stock Exchange's Official List.

The Directors are  not aware  of any  events which  have taken  place
between 30  September  2009  and  the date  of  publication  of  this
statement, which have had a material effect on the financial position
of the Company.


Enquiries: James Otter, Hygea vct plc - [e-mail]
Charles   Breese,    Hygea   vct    plc    on   01280    703482    or
[e-mail]
Roland Cornish, Beaumont Cornish Limited on 020 7628 3396

website: www.hygeavct.com

6 November 2009.

---END OF MESSAGE---




This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.